Articles On Genetic Technologies (ASX:GTG)

Title Source Codes Date
Closing Bell: ASX 200 rides Wall Street tailwinds as optimism rises

The ASX200 is riding Wall Street’s coattails today up 044% Nine out of eleven sectors were higher, with real estate leading the charge Technology was a close second with the help of a unicorn takeover bid   Wall Street rallied on Friday a...

Stockhead GTG 13 hours ago
Top 10 at 10: These ASX gold and gas stocks are meteoric on Monday

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 19 hours ago
Closing Bell: Ragusa Metals leaps 60% on lithium love; local markets follow on first glint of inflation hopes

ASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragusa Metals: up 60% Local markets took off at the open, feeling a little of the excitement which took hold of Wall Street overnight. The bench...

Stockhead GTG 4 days ago
Closing Bell: Peregrine soars, Summit slides and the UK is not OK

ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g...

Stockhead GTG 1 week ago
Closing Bell: Massive gains but Why Now, Not Later?

Small cap index up 3% ASX 200 is up 1% Wall Street jumps as The Fed asks how high The ASX 200 is up 1% and the Emerging Companies (XEC) index is about 3% higher and the wee buy now pay later’s are the heroes of the dish. But first…   Over...

Stockhead GTG 2 weeks ago
Top 10 at 10: The buy now, pay later revival rolls on

  Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mover...

Stockhead GTG 2 weeks ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead GTG 3 weeks ago
Closing Bell: Small caps jump 1.5% as exciting ideas about energy loom large across the ASX

Benchmark up circa 1%, small caps surge 1.5% Coal miners eclipsed by Whitehaven record profits Kincora Copper finds so much more copper The small cap S&P/ASX Emerging Companies (XEC) index and the benchmark S&P/ASX 200 (XJO) index...

Stockhead GTG 4 weeks ago
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work

Ansell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compounds  to >125 Genetic Technologies partners with Melbourne based Siles Health Protective personal equipment Ansell (ASX:ANN) has just annou...

Stockhead GTG 4 weeks ago
Top 10 at 10: Which ASX stocks have started the today with a bang?

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 4 weeks ago
Closing Bell: ASX coughs up coal-black furballs and Materials stops even pretending to try

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

Stockhead GTG 1 month ago
ASX Health Stocks: Another Aussie biotech gets attention in the US with a pending patent

Cynata receives notice from the US Patent Office GTG completes acquisition of AffinityDNA Dental clinic network Pacific Smiles announces earnings guidance Cell therapeutics specialist, Cynata Therapeutics (ASX:CYP), has just received a No...

Stockhead GTG 1 month ago
Top 10 at 10: Which ASX stocks are doing the heavy lifting today?

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Genetic Technologies completes acquisition of AffinityDNA

Genetic Technologies (ASX:GTG) has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.

BiotechDispatch GTG 1 month ago
Closing Bell: Volatile? The ASX 200 has criss-crossed its opening level for the 17th time today. (So that’s a yes)

The ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset big losses for energy, resources, materials. South Korea, Kiwi’s lift rates ahead of tonight’s US CPI read Investors are facing crunch time...

Stockhead GTG 1 month ago
Top 10 at 10: Which ASX stocks are floating and falling today?

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead GTG 1 month ago
Genetic Technologies (ASX:GTG) expands EasyDNA into Indian and European markets

Genetic Technologies (GTG) embarks on a significant expansion of its recent acquisition of EasyDNA in both its test portfolio and geographical reach EasyDNA had expanded the availability of its carrier testing and non-invasive prenatal tes...

themarketherald.com.au GTG 1 month ago
Closing Bell: Australia lifts small cap rate by 2%

Small Caps, ASX 200 accelerate after RBA rate call Cash rate to 1.35%, Capital Economics says 3.5% the target EasyDNA rocks GTG world   Forget the RBA, it’s small cap day at Stockhead  as the Little Legends index ignores war, floods, flu,...

Stockhead GTG 1 month ago
ASX Health Stocks: US patent another Prescient win for booming Aussie biotechs

Prescient gets US patent approval Genetic Technologies expands EasyDNA into India and Europe Imricor submits cardiac ablation catheter for EU market Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has been granted a US p...

Stockhead GTG 1 month ago
Top 10 at 10: Tuesday’s top dogs in early trade

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Closing Bell: A little Monday magic ahead of a Tuesday cash rate reality check

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Stockhead GTG 1 month ago
ASX Small Cap June Winners: PayGroup pops 164pc on unicorn interest, resources players end on a high

Literally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeover offer from US unicorn Deel Tempest Minerals signed JV to explore near the Karara Magnetite Iron mine June was a month of global econom...

Stockhead GTG 1 month ago
Top 10 at 10: These ASX hearing aid, boat building stocks are up and about in early trade

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Top 10 at 10: Which ASX stocks are high on hump day?

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Closing Bell: Nothing crypto in small caps commodity crunch

Emerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper, shares up 70%   Aussie small caps have copped a commodities shellacking to start the week as materials, metals and energy stocks bear the...

Stockhead GTG 1 month ago
ASX Health Stocks: Proteomics proves it can manufacture at scale, GTG sees pathway to the US

Proteomics has completed a manufacturing technology transfer of its PromarkerD test Genetic Technologies build model that could create pathway in the US Proteomics proves it can produce the PromarkerD tests at scale Proteomics Internation...

Stockhead GTG 1 month ago
Genetic Technologies says modelling demonstrates benefit of new test

Genetic Technologies (ASX:GTG) has completed an independently developed and validated customisable Budget Impact Model that it says demonstrates significant health and economic benefits directly attributed to the implementation of g...

BiotechDispatch GTG 1 month ago
Closing Bell: Weak leads, weak banks, a one month low and not enough energy to go round

Benchmark and small cap index down hard Life on the indices can be hard, unless your in energy, possibly materials Pearl Gull Iron is an island, literally and figuratively   The ASX200 and its emerging companies sidekick have retreated in...

Stockhead GTG 2 months ago
Closing Bell: Galileo digging all the right holes today; big miners, not so much

Both ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken China hits resources stocks Appen in trading halt after jumping 30%     Local markets took a turn for the worse on Thursday after Chinese Prem...

Stockhead GTG 2 months ago
Closing Bell: Tech on sale as risk assets start to look a lot like riskier assets

Aussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher   Rising gold prices and teetering tech stocks are playing dice for the soul of the ASX Emerging Companies (XEC) index on Wednesday, as the small cap top...

Stockhead GTG 2 months ago
Top 10 at 10: These ASX stocks are on a tear in early trade

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 2 months ago
Closing Bell: It’s a Wednesday feast on the ASX and small caps are the hero of the dish

ASX Small Cap index pops 1.4% rather nicely The top 200 ahead 1% AnteoTech and some clever diggers the big winners on Wednesday   The local small cap index is riding a mid-week mining boom with some standout individual performances from...

Stockhead GTG 2 months ago
Top 10 at 10: These ASX health and exploration stocks are top of the pile today

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 2 months ago
Genetic Technologies (ASX:GTG) to acquire AffinityDNA for just under $1m

Genetic Technologies (GTG) inks a deal to buy UK-based DNA testing company AffinityDNA for £555,000 (A$985,000) GTG will pay 50 per cent of the cost paid upfront, with the remaining 50 per cent to be paid a year after subject to the financ...

themarketherald.com.au GTG 2 months ago
ASX Health Stocks: GTG set to jump into online after buying ecommerce outfit AffinityDNA

Genetic Technologies buys out ecommerce company, AffinityDNA Regis Healthcare says it expects to be fully reimbursed by the government for its COVID-19 costs of $14m 4D Medical presents study data at renowned conference Genetic Tech buys...

Stockhead GTG 2 months ago
Top 10 at 10: The ASX stocks surfing and sinking today

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Top 10 at 10: These ASX biotech, helium stocks are rebounding in early trade

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Top 10 at 10: These ASX stocks hit the bourse with a bang today

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Top 10 at 10: These ASX stocks are ending the month on a high

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Closing Bell: Small caps flat, benchmark rises on resurgent resources

The S&P/ASX 200 reclaimed more than 1% in Thursday trade after copping a straight hat-trick of losses. The major energy names and big Papa miners like Rio, Fortescue and BHP climbing strongly after falling even more strongly these last...

Stockhead GTG 3 months ago
Check Up: Money managers are still bullish on Healthcare; here’s what they said

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Stockhead GTG 3 months ago
Closing Bell: A fintech flyer as the ASX follows Wall Street into the red on Friday

The ASX will head into the Anzac day long weekend on a slightly sour note following a Friday selloff. For the microcap Emerging Companies index, it was a ~1.5% fall on the day — but that didn’t stop another triple-digit percentage return, t...

Stockhead GTG 3 months ago
Top 10 at 10: These ASX stocks have plenty of admirers this morning

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Stockhead GTG 4 months ago
Closing Bell: Small caps go full Maximus, unleash gains in face of rising broad-based fears

Okay, who poked the S&P/ASX Emerging Companies index (XEC) this morning? Someone woke the sleeping Spinosaurus – the largest carnivorous dinosaur on this planet – that lies at the heart of our beloved small cap thermometer. It started r...

Stockhead GTG 4 months ago
Closing Bell: Small caps, all caps down; Block suffers After pain and China hurts

With Tuesday trade in the casket, the ASX Emerging Companies (XEC) index has closed about 1% lower, while the ASX 200 (XJO) benchmark index is down 0.5%, Everywhere markets fell, but for Paris, which has breathed a rich, garlic-scented merd...

Stockhead GTG 4 months ago
Closing Bell: Good Friday is coming, let’s hope it makes up for Bad Monday

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

Stockhead GTG 4 months ago
Top 10 at 10: These ASX semiconductor, exploration stocks are outshining the rest

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 4 months ago
Closing Bell: International Graphite climbs 97.5% in its first session, all else is dust

The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow...

Stockhead GTG 4 months ago